TCMDTACTILE SYSTEMS TECHNOLOGY INC(TCMD)Stock Analysis

AI analysis on 2,800+ stocks →
HealthcareNasdaqsmall
Institutional-grade research for retail investors
SEC EDGAR: CIK 1027838TCMD stock profile & AI dashboard →

13F Pro Quality Score

56.1/100

Rank #1,204 of 2,962 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

68.0/100

Profitability

60.8/100

Balance Sheet

83.5/100

Earnings Quality

67.4/100

Free Cash Flow

49.4/100

Institutional Flow

42.9/100

Revenue Scale

32.2/100

Dilution Risk

36.0/100
Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

TCMD Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for TACTILE SYSTEMS TECHNOLOGY INC (TCMD), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores TCMD at 56.1/100 on a 32-signal composite quality model, placing it at rank #1,204 of 2,962 stocks — the top half of the AI-ranked universe. TCMD scores in the top quartile across balance sheet strength (83.5). Areas of concern include revenue scale (32.2), which score below median versus the broader universe. Shareholder dilution risk is elevated at 36.0/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), TACTILE SYSTEMS TECHNOLOGY INC reports quarterly revenue of $85.7M, net income of $7.8M, an operating margin of 8.0%. Top institutional holders of TCMD by reported 13-F value include BlackRock, CADIAN CAPITAL MANAGEMENT, DIMENSIONAL FUND ADVISORS, based on the most recent SEC filings. TCMD trades on the Nasdaq exchange and files with the SEC under CIK 1027838. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TCMD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for TACTILE SYSTEMS TECHNOLOGY INC directly from SEC EDGAR. TACTILE SYSTEMS TECHNOLOGY INC's 13F Pro composite quality score has ranged between 30 and 65 since 2021, currently 56.1 — an improving long-term trajectory across 68 quarterly and live scoring snapshots.

Fun facts about TACTILE SYSTEMS TECHNOLOGY INC

Quirks, history, and lore behind TCMD — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. medical device company · small-cap · listed on Nasdaq · headquartered in Minnesota.
  • 2
    The Numbers
    Annual revenue in the range of $200–250 million — not a giant, but it dominates a very specific niche in home medical equipment.
  • 3
    The History
    Founded in the 1990s, the company built its business around treating conditions that cause fluid to back up in the body's tissues — a problem most people have never heard of.
  • 4
    The Secret
    Its core products are pneumatic compression devices worn on the limbs — essentially high-tech inflatable sleeves that keep circulation moving in patients who can't do it naturally.
  • 5
    The Lore
    Its primary market is lymphedema and chronic venous insufficiency patients — conditions affecting millions but chronically underserved by big-name medtech players.
  • 6
    The Giveaway
    The name literally spells out its mission: making tactile, hands-on compression therapy available at home — ticker TCMD, a small Nasdaq name with a very squeezable product line.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q2 2026

$85.7M

Net Income

Q2 2026

$7.8M

Free Cash Flow

Q2 2026

$2.0M

Operating Margin

Q2 2026

8.0%

ROIC

Q2 2026

12.2%

D/E Ratio

Q2 2026

0.00

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+12.5% YoY
$329.5MFY 2025
FY22 $246.8MFY23 $274.4MFY24 $293.0MFY25 $329.5M

Net Income

+12.5% YoY
$19.1MFY 2025
FY22 $-17.9MFY23 $28.5MFY24 $17.0MFY25 $19.1M

Operating Income

+32.0% YoY
$29.3MFY 2025
FY22 $-12.8MFY23 $18.0MFY24 $22.2MFY25 $29.3M

EPS (Diluted)

+17.1% YoY
$0.82FY 2025
FY22 $-0.89FY23 $1.23FY24 $0.70FY25 $0.82

Total Assets

-8.0% YoY
$273.9MFY 2025
FY22 $255.0MFY23 $281.4MFY24 $297.9MFY25 $273.9M

Total Debt

$0.00FY 2025
FY22 FY23 $16.8MFY24 FY25 $0.00

Op. Cash Flow

+5.3% YoY
$42.8MFY 2025
FY22 $5.2MFY23 $35.9MFY24 $40.7MFY25 $42.8M

Free Cash Flow

+5.7% YoY
$40.4MFY 2025
FY22 $3.4MFY23 $33.5MFY24 $38.3MFY25 $40.4M

Get alerted when TCMD's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for TACTILE SYSTEMS TECHNOLOGY INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Companies Similar to TCMD

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

NATR

NATURES SUNSHINE PRODUCTS INC

51
AI score
Similar quality profile · 8 shared holders
VCEL

Vericel Corp

62
AI score
Similar quality profile · 7 shared holders
MD

Pediatrix Medical Group, Inc.

55
AI score
Similar quality profile · 17 shared holders
VCYT

VERACYTE, INC.

67
AI score
Similar quality profile · 12 shared holders
ELMD

Electromed, Inc.

61
AI score
Similar quality profile · 4 shared holders
HCSG

HEALTHCARE SERVICES GROUP INC

61
AI score
Similar quality profile · 11 shared holders

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

Put TCMD on your watchlist

Track score changes the day TACTILE SYSTEMS TECHNOLOGY INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is TCMD a good stock to buy?

13F Pro's AI-powered analysis of TACTILE SYSTEMS TECHNOLOGY INC (TCMD) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for TCMD are available on the TCMD stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. TCMD is classified as a small company.

Which hedge funds own TCMD?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling TCMD. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of TACTILE SYSTEMS TECHNOLOGY INC's investment landscape.